WEBINAR: The CMS Transparency Rule: Strategic Considerations for Hospitals
Tuesday, August 11, 2020
1 - 1:30 p.m. EDT
In late June, a federal court upheld the Trump Administration’s 2020 Price Transparency Rule, which requires hospitals to disclose their charges and payer-specific negotiated rates for all services they provide. The legal issues are straightforward yet many strategic questions remain regarding what provider executives need to do next to prepare for the rule, including:
• Is the rule settled and will there be an appeal?
• What does compliance with the rule look like and what are consequences of non-compliance?
• How might this affect hospital pricing strategies and overall market dynamics?
• What shoppable services should providers actually post, and why?
• How should hospitals approach contract modeling around price transparency?
• What will be the downstream revenue effects?
• Will COVID-19-related utilization changes affect price transparency?
Massachusetts has had statewide transparency requirements in place prior to the CMS rule, and our faculty will review how these regulations have affected hospital strategies and operations feeding into the federal rule. They will then discuss the high-level tactical considerations. Join experts from Guidehouse’s Managed Care and Pricing Strategy team for this complimentary webinar regarding the critical next steps for hospital finance executives as the price transparency rule evolves.
Jeff Leibach, Director of Healthcare Strategic Solutions, Guidehouse
Jeff Leibach is Director with Guidehouse's Healthcare Strategic Solutions team, supporting clients as they manage the financial and strategic challenges in today's rapidly changing healthcare landscape. Jeff's areas of expertise include managed care negotiations, pricing, and reimbursement analytics, and aligning clinical and financial leadership as providers and payers weigh the transition from fee-for-service to value-based care. Jeff has led development of several of Guidehouse's proprietary analytic models that create actionable insights from large claims data sets. Additionally, Jeff leads training programs for healthcare executives focused on managed care strategy, value-based care, and negotiations independently and in collaboration with the Kellogg School of Management.
Jeffrey A. Meyers, Director of Healthcare Strategy, Guidehouse
Jeff Meyers is a Director in the Healthcare Strategy group at Guidehouse, LP, supporting clients managing the strategic challenges of the healthcare environment. As part of Guidehouse’s support of clients during the COVID-19 pandemic, Jeff leads the firm’s regulatory efforts in tracking federal and state COVID-19 response funding and the coordination of benefits across all funding opportunities. Prior to joining Guidehouse, he served as the Commissioner of the New Hampshire Department of Health and Human Services from January 2016 to December 2019.
As commissioner, he led a reorganization of the department to achieve integration of programs and funding streams in order to serve New Hampshire citizens more effectively. He also led initiatives to implement a new Hub and Spoke delivery system to address the Opioid Crisis and actively managed a major behavioral health Medicaid waiver, re-procurement of the state’s Medicaid managed care program and much-needed reforms to the state’s child welfare system.
Over the course of his career, Jeff has served in a number of public and private sector positions, including as Chief Legal Counsel to New Hampshire Governor John H. Lynch, Legal Counsel to the New Hampshire State Senate, Assistant Attorney General of the State of New Hampshire, and Associate and Secretary of Kissinger Associates, Inc. in New York City. Jeff is a graduate of The George Washington University (B.A.) and of Georgetown University Law School (J.D.). He is admitted to the bar of New Hampshire, Maine, and Vermont, and is an active member of the National Academy for State Health Policy and the American Health Lawyers Association.